FR2324303B2 - - Google Patents

Info

Publication number
FR2324303B2
FR2324303B2 FR7524242A FR7524242A FR2324303B2 FR 2324303 B2 FR2324303 B2 FR 2324303B2 FR 7524242 A FR7524242 A FR 7524242A FR 7524242 A FR7524242 A FR 7524242A FR 2324303 B2 FR2324303 B2 FR 2324303B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7524242A
Other languages
French (fr)
Other versions
FR2324303A2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority to FR7524242A priority Critical patent/FR2324303A2/fr
Publication of FR2324303A2 publication Critical patent/FR2324303A2/fr
Application granted granted Critical
Publication of FR2324303B2 publication Critical patent/FR2324303B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/83—Thioacids; Thioesters; Thioamides; Thioimides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7524242A 1975-08-04 1975-08-04 Pharmaceutical compsn. contg. nicotinamide-(N)-ethyl nicotinate - for treatment of disorders caused by hyperlipidemia Granted FR2324303A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7524242A FR2324303A2 (en) 1975-08-04 1975-08-04 Pharmaceutical compsn. contg. nicotinamide-(N)-ethyl nicotinate - for treatment of disorders caused by hyperlipidemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524242A FR2324303A2 (en) 1975-08-04 1975-08-04 Pharmaceutical compsn. contg. nicotinamide-(N)-ethyl nicotinate - for treatment of disorders caused by hyperlipidemia

Publications (2)

Publication Number Publication Date
FR2324303A2 FR2324303A2 (en) 1977-04-15
FR2324303B2 true FR2324303B2 (ja) 1979-06-15

Family

ID=9158716

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7524242A Granted FR2324303A2 (en) 1975-08-04 1975-08-04 Pharmaceutical compsn. contg. nicotinamide-(N)-ethyl nicotinate - for treatment of disorders caused by hyperlipidemia

Country Status (1)

Country Link
FR (1) FR2324303A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209788B (it) * 1980-10-21 1989-08-30 Celesio Sonnino Tauro Sostanza ipolipidemizzante (bis-tio-etil-nicotinato)-1,10-decano

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245347A1 (en) * 1973-10-01 1975-04-25 Istituto Ganassini Ricerche Bi Aminoalkyl thionicotinates - with hypocholesterolaemic, hypolipaemic, antiinflammatory and antibradykinin activity

Also Published As

Publication number Publication date
FR2324303A2 (en) 1977-04-15

Similar Documents

Publication Publication Date Title
AU495829B2 (ja)
CH606830A5 (ja)
CH588775A5 (ja)
BG21736A1 (ja)
BG22009A1 (ja)
BG22137A1 (ja)
BG22756A1 (ja)
BG22941A1 (ja)
BG23151A1 (ja)
CH1667475A4 (ja)
CH583485A5 (ja)
CH606982A5 (ja)
CH588789A5 (ja)
CH590107A5 (ja)
CH590628A5 (ja)
CH590986A5 (ja)
CH591762A5 (ja)
CH593593A5 (ja)
CH594270A5 (ja)
CH594760A5 (ja)
CH595250A5 (ja)
CH595644A5 (ja)
CH595661A5 (ja)
CH596120A5 (ja)
CH596442A5 (ja)